Biomarkers and new-onset atrial fibrillation to assess atrial cardiomyopathy

Int J Cardiol. 2017 Dec 1:248:208-210. doi: 10.1016/j.ijcard.2017.08.031.

Authors

Dominik Linz¹, Adrian D Elliott¹, Thomas H Marwick², Prashanthan Sanders³

Affiliations

¹ Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.
² Baker Heart and Diabetes Institute, Melbourne, Australia.
³ Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia. Electronic address: [email protected].

PMID: 28942873
DOI: 10.1016/j.ijcard.2017.08.031

No abstract available

Publication types

Editorial
Comment

MeSH terms

Atrial Fibrillation*
Biomarkers
Cardiomyopathies*
Humans

Substances

Biomarkers